Compare IQV & HUBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | HUBB |
|---|---|---|
| Founded | 1982 | 1888 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6B | 23.5B |
| IPO Year | 2013 | 2004 |
| Metric | IQV | HUBB |
|---|---|---|
| Price | $168.96 | $534.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 8 |
| Target Price | $227.13 | ★ $517.88 |
| AVG Volume (30 Days) | ★ 1.2M | 495.2K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.08% |
| EPS Growth | 4.67 | ★ 15.10 |
| EPS | 7.84 | ★ 16.54 |
| Revenue | ★ $9,739,000,000.00 | $5,844,600,000.00 |
| Revenue This Year | $6.78 | $10.34 |
| Revenue Next Year | $5.88 | $5.47 |
| P/E Ratio | ★ $22.03 | $31.96 |
| Revenue Growth | ★ 41.60 | 3.84 |
| 52 Week Low | $134.65 | $325.08 |
| 52 Week High | $247.05 | $533.80 |
| Indicator | IQV | HUBB |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 65.56 |
| Support Level | $159.42 | $416.52 |
| Resistance Level | $170.89 | N/A |
| Average True Range (ATR) | 6.19 | 15.62 |
| MACD | 1.31 | 5.38 |
| Stochastic Oscillator | 36.04 | 96.90 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.